Your Article Summary
See Latest ArticlesLL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline
Journal of Immunology, 06/30/09
Bergsson G et al. - Data suggest glycosaminoglycan–LL-37 complexes to be potential therapeutic targets. Factors that disrupt glycosaminoglycan–LL-37 aggregates promote the antimicrobial effects of LL-37 with the caveat that concomitant administration of antiproteases may be needed to protect the now liberated LL-37 from proteolytic cleavage.
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005
Journal of Cystic Fibrosis , 12/04/09
Evaluation of salt supplementation in CF infants
Journal of Cystic Fibrosis , 12/03/09
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
European Respiratory Journal , 11/24/09